CBRE vs KMTS · P/E 43, rev $21.75B vs rev $95.1M
CBRE Group Inc Class A (CBRE) versus Kestra Medical Technologies, Ltd. Common Stock (KMTS) — a side-by-side from cached financials, not a winner call.
CBRE Group Inc Class A (CBRE) is a real estate services company listed on US.
Kestra Medical Technologies, Ltd. Common Stock (KMTS) is a medical instruments & supplies company listed on US.
Latest reported CBRE revenue for 2026-06-30 was $21.75B. Net income was $522.0M. CBRE currently screens at market cap $41.66B and trailing P/E 42.7.
Latest reported KMTS revenue for 2026-04-30 was $95.1M. Net income was -$131.6M. Revenue was up 59.0% from 2025-04-30 to 2026-04-30. KMTS currently screens at market cap $1.24B.
CBRE currently screens at market cap $41.66B and trailing P/E 42.7. KMTS currently screens at market cap $1.24B.
Not investment advice. Open the CBRE and KMTS stock pages for the full models.
Not investment advice.